Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF3 | O95398 | 17/20 | 0.66 |
| ▸ | RAPGEF4 | Q8WZA2 | 5/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20523678 | 0.80 | RAPGEF3 (1.00) | RAPGEF3RAPGEF4MAPTNPSR1 | |
| SCHEMBL19501265 | 0.79 | RAPGEF3 (0.54) | RAPGEF3RAPGEF4MAPTNPSR1 | |
| SCHEMBL15188849 | 0.76 | RAPGEF3 (1.00) | RAPGEF3 | |
| SCHEMBL15941311 | 0.76 | RAPGEF3 (1.00) | RAPGEF3 | |
| SCHEMBL8745992 | 0.76 | RAPGEF3 (0.52) | RAPGEF3RAPGEF4MAPTNPSR1 | |
| SCHEMBL20523703 | 0.73 | RAPGEF3 (1.00) | RAPGEF3RAPGEF4 | |
| SCHEMBL20523697 | 0.72 | RAPGEF3 (1.00) | RAPGEF3RAPGEF4 | |
| SCHEMBL16664631 | 0.71 | RAPGEF3 (0.88) | RAPGEF3 | |
| SCHEMBL20838578 | 0.71 | RAPGEF3 (0.57) | RAPGEF3RAPGEF4MAPTNPSR1 | |
| SCHEMBL20523743 | 0.69 | RAPGEF3 (1.00) | RAPGEF3RAPGEF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0412211-A1 | Cancer therapy system | THERAPEUTICAL SYSTEMS CORPORATION (US) | 1991-02-13 | — | — | EP | disclosed |
| US-4935450-A | Cancer therapy system for effecting oncolysis of malignant neoplasms | THERAPEUTICAL SYSTEMS CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
| US-4724234-A | ADMINISTERING NUTRITIONAL REGIMEN AND AGENTS WHICH UNCOUPLE OXIDATIVE PHOSPHORYLATION | THERAPEUTICAL SYSTEMS CORP. (US) | 1988-02-09 | — | — | US | disclosed |